Fundraising FoxCarbylan Therapeutics
Palo Alto, US · Delaware corporation · 1 known investors
Find your way into Carbylan Therapeutics
Sign up to see every warm intro you have to Carbylan Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Carbylan Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MM
MARCEE M. MARONEYExecutive
DG
DAVID GRAVETTExecutive
TM
T. MICHAEL WHITEExecutive
HL
HAYLEY LEWISExecutive
DM
DAVID M. RENZIExecutive
TL
TIMOTHY L. TRAPPExecutive
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$9M disclosed across 2 rounds · 2014–2015
▶$4MraisedMar 2015 · 4 investors · Other Health CareRule 506(b)
▶$4MraisedMar 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID CLAPPERDirector
- ALBERT CHADirector
- EDWARD W. UNKARTDirector
- GUY P. NOHRADirector
- MARCEE M. MARONEYExecutive Officer
- DAVID GRAVETTExecutive Officer
- KEITH A. KATKINDirector
- T. MICHAEL WHITEExecutive Officer
- REZA ZADNODirector
- HAYLEY LEWISExecutive Officer
- STEVEN L. BASTADirector
- DAVID M. RENZIExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2014 · 4 investors · Other Health CareRule 506(b)
▶$5MraisedOct 2014 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- STEVEN BASTADirector
- DAVID GRAVETTExecutive Officer
- GUY P. NOHRADirector
- HAYLEY LEWISExecutive Officer
- MARCEE M. MARONEYExecutive Officer
- ALBERT CHADirector
- DAVID M. RENZIExecutive Officer, Director
- T. MICHAEL WHITEExecutive Officer
- REZA ZADNODirector
- TIMOTHY L. TRAPPExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Carbylan Therapeutics's investors?
- Carbylan Therapeutics's investors include Alta Partners.
- How much funding has Carbylan Therapeutics raised?
- Carbylan Therapeutics has disclosed $9M raised across 2 rounds.
- Where is Carbylan Therapeutics headquartered?
- Carbylan Therapeutics is headquartered in Palo Alto, US.